Apatinib for patients with unresectable high-grade osteosarcoma progressing after standard chemotherapy: A multi-center retrospective study.

Wenxi Yu,Xiuchun Yu,Sujia Wu,Li-Na Tang,Shui’er Zheng,Yan Zhou,Yujing Huang,Guowei Qian,Hongtao Li,Jianjun Zhang,Ai-Na He,Yonggang Wang,Haiyan Hu,Feng Lin,Zan Shen,Yang Yao

Apatinib for patients with unresectable high-grade osteosarcoma progressing after standard chemotherapy: A multi-center retrospective study.

2017

Wenxi Yu
Xiuchun Yu
Sujia Wu
Li-Na Tang
Shui’er Zheng
Yan Zhou
Yujing Huang
Guowei Qian
Hongtao Li
Jianjun Zhang
Ai-Na He
Yonggang Wang
Haiyan Hu
Feng Lin
Zan Shen
Yang Yao

11031Background: Prognosis for patients with relapsed/metastatic osteosarcoma is dismal and the optimal treatment strategy remains to be refined. Sorafenib and sorafenib plus everolimus are the onl...

Keywords:

Physical therapy
Apatinib
General surgery
Retrospective cohort study
Osteosarcoma
Medicine
Chemotherapy
Sorafenib
Everolimus
Metastatic osteosarcoma
Oncology
Internal medicine
optimal treatment
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations